Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05633888 · ClinicalTrials.gov registry record · NA
Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System
A NA study of Sacroiliac Joint Disruption and Degenerative Sacroiliitis, sponsored by Tenon Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 6
- Study locations
NCT05633888: Recruiting NA study of Sacroiliac Joint Disruption and Degenerative Sacroiliitis, sponsored by Tenon Medical.
NCT05633888 is a NA study of Sacroiliac Joint Disruption and Degenerative Sacroiliitis that is actively recruiting participants, run by Tenon Medical. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05633888, a NA study of Sacroiliac Joint Disruption and Degenerative Sacroiliitis, is actively recruiting participants, sponsored by Tenon Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to evaluate the outcomes of patients with sacroiliac joint pain treated with the CATAMARAN SI Joint Fusion System.
Conditions Studied
Interventions
- DEVICE CATAMARAN SI Joint Fusion System
Study Locations (6)
Idaho
- Northwest Specialty Hospital - Coeur d'Alene
Indiana
- Comprehensive Pain and Spine Specialists - Muncie
Kentucky
- Vitality Pain Centers - Louisville
Minnesota
- Orthopedic Associates of Duluth - Duluth
Missouri
- St. Louis Pain Consultants - Chesterfield
Utah
- St. George Orthopedic Spine - St. George
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-11-14 |
| Est. Completion | 2026-01 |
| Phase | NA |
What NCT05633888 shows while recruiting
NCT05633888 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Sacroiliac Joint Disruption appearing as the primary indexed condition, and to 1 intervention - of which CATAMARAN SI Joint Fusion System is the first listed.
NCT05633888 lists 6 locations in 6 states (Idaho, Indiana, Kentucky).
Frequently Asked Questions
What is clinical trial NCT05633888 about?
NCT05633888 is a clinical study titled "Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System". The purpose of this study is to evaluate the outcomes of patients with sacroiliac joint pain treated with the CATAMARAN SI Joint Fusion System.
What is the current status of trial NCT05633888?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-11-14. Estimated completion is 2026-01.
What conditions does trial NCT05633888 study?
This clinical trial studies the following conditions: Sacroiliac Joint Disruption, Degenerative Sacroiliitis.
What interventions are being tested in trial NCT05633888?
The interventions under investigation include: CATAMARAN SI Joint Fusion System (DEVICE).
Who is sponsoring clinical trial NCT05633888?
This trial is sponsored by Tenon Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05633888 being conducted?
This trial has 6 study locations across Idaho, Indiana, Kentucky, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05633888's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI